Role of Neutrophil-lymphocyte Ratio as Short-term Outcome Prognostic Indicator Following an Acute ST Segment Elevation Myocardial Infarction-A Prospective Observational Study
Correspondence Address :
Dr. Swati Hegde,
Assistant Professor, Department of General Medicine, Ramaiah Medical College,
Bangalore, Karnataka, India.
E-mail: swatihegde2006@yahoo.co.in
Introduction: The ratio of Neutrophils to Lymphocytes (NLR) has recently arisen as a likely biomarker to forecast clinical outcomes in Ischaemic Heart Disease (IHD). The NLR in cases of ST Elevation Myocardial Infarction (STEMI) with respect to survival outcomes and complications is not well established in literature and was evaluated in the present study.
Aim: To study the association of NLR with complications and mortality following acute STEMI.
Materials and Methods: A short-term prospective observational study was conducted in 102 participants diagnosed with STEMI. The study was conducted at tertiary care hospital from October 2015 to September 2017. Haematological, serological and radiographical findings were obtained and compared between survivors and non survivors. Receiver Operator Curve (ROC) and Area Under the Curve (AUC) analysis were performed to analyse the utility of NLR in predicting mortality and major complications.
Results: The mean age of patients was 64.12±14.82 years and 75.5% of them were male. Non survivors (9.8%) had a greater incidence of cardiogenic shock (p-value <0.00049), pulmonary oedema (p-value <0.01199) and tachyarrhythmia (p-value <0.00049) compared to survivors. The ROC and AUC analysis showed that a higher NLR had a sensitivity of 80% in detecting mortality, 77.78% in detecting cardiogenic shock and 80% in detecting pulmonary oedema.
Conclusion: Higher NLR can be a useful prognostic marker for predicting short-term mortality and acute complications following an acute STEMI.
Acute coronary syndrome, Complication, Morbidity, Mortality, Prognosis
10.7860/JCDR/2021/51766.15719
Date of Submission: Aug 05, 2021
Date of Peer Review: Sep 28, 2021
Date of Acceptance: Oct 26, 2021
Date of Publishing: Dec 01, 2021
AUTHOR DECLARATION:
• Financial or Other Competing Interests: None
• Was Ethics Committee Approval obtained for this study? Yes
• Was informed consent obtained from the subjects involved in the study? Yes
• For any images presented appropriate consent has been obtained from the subjects. NA
PLAGIARISM CHECKING METHODS:
• Plagiarism X-checker: Aug 06, 2021
• Manual Googling: Oct 23, 2021
• iThenticate Software: Nov 15, 2021 (11%)
ETYMOLOGY: Author Origin
- Emerging Sources Citation Index (Web of Science, thomsonreuters)
- Index Copernicus ICV 2017: 134.54
- Academic Search Complete Database
- Directory of Open Access Journals (DOAJ)
- Embase
- EBSCOhost
- Google Scholar
- HINARI Access to Research in Health Programme
- Indian Science Abstracts (ISA)
- Journal seek Database
- Popline (reproductive health literature)
- www.omnimedicalsearch.com